Skip to main content
PMC home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1997 Apr;35(4):948–950. doi: 10.1128/jcm.35.4.948-950.1997

Rapid screening of point mutations of the Neisseria gonorrhoeae parC gene associated with resistance to quinolones.

T Deguchi 1, M Yasuda 1, M Nakano 1, E Kanematsu 1, S Ozeki 1, Y Nishino 1, T Ezaki 1, S Maeda 1, I Saito 1, Y Kawada 1
PMCID: PMC229706  PMID: 9157158

Abstract

To detect quinolone resistance-associated mutations within the Asp-86, Ser-87, Ser-88, and Glu-91 codons of the Neisseria gonorrhoeae parC gene, we developed a rapid and simple assay based on amplification of the regions of the parC gene containing the mutations sites by PCR and digestion of the PCR products with restriction enzymes. By using the method of primer-specified restriction site modification, artificial SalI, PstI, EcoRI, and HinfI restriction sites were created in the regions containing the Asp-86, Ser-87, Ser-88, and Glu-91 codons, respectively. The mutations generating alterations at Asp-86, Ser-87, Ser-88, and Glu-91 were detected as failures of SalI, PstI, EcoRI, and HinfI to digest the respective PCR products. Fifty-five clinical strains of N. gonorrhoeae were examined for mutations in the parC gene by this assay. Appropriate mutations at either the Asp-86, Ser-87, Ser-88, or Glu-91 codon were detected in each of 11 strains in which a mutation had previously been observed by DNA sequencing. This rapid and simple assay could be a useful device for screening genetic alterations in the parC gene associated with resistance to quinolones in N. gonorrhoeae.

Full Text

The Full Text of this article is available as a PDF (282.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Belland R. J., Morrison S. G., Ison C., Huang W. M. Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone-resistant isolates. Mol Microbiol. 1994 Oct;14(2):371–380. doi: 10.1111/j.1365-2958.1994.tb01297.x. [DOI] [PubMed] [Google Scholar]
  2. Birley H., McDonald P., Carey P., Fletcher J. High level ciprofloxacin resistance in Neisseria gonorrhoeae. Genitourin Med. 1994 Aug;70(4):292–293. doi: 10.1136/sti.70.4.292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Corkill J. E., Percival A., Lind M. Reduced uptake of ciprofloxacin in a resistant strain of Neisseria gonorrhoeae and transformation of resistance to other strains. J Antimicrob Chemother. 1991 Oct;28(4):601–604. doi: 10.1093/jac/28.4.601. [DOI] [PubMed] [Google Scholar]
  4. Deguchi T., Yasuda M., Asano M., Tada K., Iwata H., Komeda H., Ezaki T., Saito I., Kawada Y. DNA gyrase mutations in quinolone-resistant clinical isolates of Neisseria gonorrhoeae. Antimicrob Agents Chemother. 1995 Feb;39(2):561–563. doi: 10.1128/aac.39.2.561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Deguchi T., Yasuda M., Nakano M., Ozeki S., Ezaki T., Maeda S., Saito I., Kawada Y. Rapid detection of point mutations of the Neisseria gonorrhoeae gyrA gene associated with decreased susceptibilities to quinolones. J Clin Microbiol. 1996 Sep;34(9):2255–2258. doi: 10.1128/jcm.34.9.2255-2258.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Deguchi T., Yasuda M., Nakano M., Ozeki S., Ezaki T., Saito I., Kawada Y. Quinolone-resistant Neisseria gonorrhoeae: correlation of alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV with antimicrobial susceptibility profiles. Antimicrob Agents Chemother. 1996 Apr;40(4):1020–1023. doi: 10.1128/aac.40.4.1020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Georgiou M., Muñoz R., Román F., Cantón R., Gómez-Lus R., Campos J., De La Campa A. G. Ciprofloxacin-resistant Haemophilus influenzae strains possess mutations in analogous positions of GyrA and ParC. Antimicrob Agents Chemother. 1996 Jul;40(7):1741–1744. doi: 10.1128/aac.40.7.1741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gransden W. R., Warren C. A., Phillips I., Hodges M., Barlow D. Decreased susceptibility of Neisseria gonorrhoeae to ciprofloxacin. Lancet. 1990 Jan 6;335(8680):51–51. doi: 10.1016/0140-6736(90)90177-7. [DOI] [PubMed] [Google Scholar]
  9. Haliassos A., Chomel J. C., Tesson L., Baudis M., Kruh J., Kaplan J. C., Kitzis A. Modification of enzymatically amplified DNA for the detection of point mutations. Nucleic Acids Res. 1989 May 11;17(9):3606–3606. doi: 10.1093/nar/17.9.3606. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hooper D. C., Wolfson J. S. Fluoroquinolone antimicrobial agents. N Engl J Med. 1991 Feb 7;324(6):384–394. doi: 10.1056/NEJM199102073240606. [DOI] [PubMed] [Google Scholar]
  11. Jephcott A. E., Turner A. Ciprofloxacin resistance in gonococci. Lancet. 1990 Jan 20;335(8682):165–165. doi: 10.1016/0140-6736(90)90035-4. [DOI] [PubMed] [Google Scholar]
  12. Kam K. M., Wong P. W., Cheung M. M., Ho N. K., Lo K. K. Quinolone-resistant Neisseria gonorrhoeae in Hong Kong. Sex Transm Dis. 1996 Mar-Apr;23(2):103–108. doi: 10.1097/00007435-199603000-00003. [DOI] [PubMed] [Google Scholar]
  13. Stein D. C., Danaher R. J., Cook T. M. Characterization of a gyrB mutation responsible for low-level nalidixic acid resistance in Neisseria gonorrhoeae. Antimicrob Agents Chemother. 1991 Apr;35(4):622–626. doi: 10.1128/aac.35.4.622. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Tanaka M., Fukuda H., Hirai K., Hosaka M., Matsumoto T., Kumazawa J. Reduced uptake and accumulation of norfloxacin in resistant strains of Neisseria gonorrhoeae isolated in Japan. Genitourin Med. 1994 Aug;70(4):253–255. doi: 10.1136/sti.70.4.253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Tanaka M., Kumazawa J., Matsumoto T., Kobayashi I. High prevalence of Neisseria gonorrhoeae strains with reduced susceptibility to fluoroquinolones in Japan. Genitourin Med. 1994 Apr;70(2):90–93. doi: 10.1136/sti.70.2.90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Tapsall J. W., Limnios E. A., Thacker C., Donovan B., Lynch S. D., Kirby L. J., Wise K. A., Carmody C. J. High-level quinolone resistance in Neisseria gonorrhoeae: a report of two cases. Sex Transm Dis. 1995 Sep-Oct;22(5):310–311. doi: 10.1097/00007435-199509000-00007. [DOI] [PubMed] [Google Scholar]
  17. Tapsall J. W., Shultz T. R., Lovett R., Munro R. Failure of 500 mg ciprofloxacin therapy in male urethral gonorrhoea. Med J Aust. 1992 Jan 20;156(2):143–143. doi: 10.5694/j.1326-5377.1992.tb126457.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES